Overview: Epirubicin HCl 10 mg Injection (Lyophilised) is a prescription chemotherapy medicine containing Epirubicin Hydrochloride (10 mg) used in the treatment of various cancers including breast cancer and lymphoma by inhibiting DNA replication in rapidly dividing cancer cells. Key Benefits: – Effective treatment option in solid tumors and hematologic cancers – Inhibits cancer cell DNA synthesis to slow tumor growth – Used in combination chemotherapy regimens Composition: Epirubicin Hydrochloride (10 mg) How It Works: Epirubicin intercalates into DNA and inhibits topoisomerase II, preventing DNA replication and leading to cancer cell death, especially in fast-growing tumor cells. Usage Instructions: – Administer only under supervision of qualified healthcare professionals – Dosage and schedule determined by cancer type and patient condition – Not for self-administration Side Effects: – Bone marrow suppression (low blood counts) – Nausea, vomiting, hair loss – Mouth sores, fatigue Precautions: – Regular monitoring of blood counts and cardiac function is essential – Increased infection and bleeding risk due to immune suppression – Not recommended during pregnancy or breastfeeding unless clearly advised Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.